Neonatal Kidney Health Follow-Up Program
The goal of the program is to systematically follow neonatal patients with acute kidney injury (AKI) and identify both short and long-term outcomes. This follow-up research project will be in concert with ongoing clinical care in the Neonatal Kidney Health Follow-Up Program.
• Systematically and prospectively document the incidence of chronic kidney disease (CKD) in the neonatal population following an episode acute kidney injury (AKI) episode and identify short and long-term outcomes.
• Develop a predictive model of developing chronic kidney disease after an episode of acute kidney injury, predicting that neonates with more sever forms of pediatric AKI will be more likely to develop CKD
-The study team will collect any left-over urine that participants give for their doctor. We will use this urine to perform the urinary biomarker research tests. If there is no left-over urine, we will ask the participant to give us a urine sample. This will take 5-10 minutes. Urinary biomarkers available at time of each visit (5-10ml) to be processed and analyzed in the Nephrology Biomarker Lab at CCHMC.
-The study team will collect data from the participant's medical record for information related to the AKI diagnosis.
- IRB Number: 2002195483
- Research Study Identifier: TX11075
Recruitment StatusEnrolling By Invitation
If you need help finding a study or have any questions, please contact us at firstname.lastname@example.org or by phone at (888) 264-0005.